Spatial multiomics sequencing platform for precision diagnostics
Singular Genomics builds hardware and firmware for spatial pathology—specifically the G4X platform, a high-throughput sequencer for in situ multiomics. The tech stack is embedded-heavy (C/C++, RTOS, I2C, UART, CAN, USB protocols) paired with Illumina NovaSeq integration, typical of precision instrumentation. Current hiring is weighted toward director and senior roles in engineering and marketing, with active projects spanning platform firmware, assay development, and demand generation—suggesting a phase shift from product maturation toward market adoption and workflow standardization.
Notable leadership hires: Marketing Director
Singular Genomics is a San Diego-based public company founded in 2016 that develops spatial multiomics sequencing instruments for research and clinical diagnostics. The G4X platform is designed to deliver high-throughput in situ analysis, enabling researchers and labs to profile multiple molecular modalities in tissue context. The company's immediate technical priorities include firmware robustness for both the G4 and G4X sequencers, assay optimization for reproducibility, and integration of spatial data workflows. Sales and go-to-market activity center on adoption of the spatial platform among research institutions and diagnostic labs.
The G4X is a high-throughput in situ multiomics sequencer designed for spatial pathology and precision diagnostics. It integrates Illumina NovaSeq technology with Singular's custom firmware and embedded protocols (RTOS, I2C, UART, CAN, USB) to deliver spatial analysis in tissue samples.
Singular runs C/C++ firmware on RTOS with embedded protocols (I2C, UART, CAN, USB, Ethernet, RS-232/485). The platform integrates Illumina NovaSeq 6000 sequencers and uses ImageJ for image analysis and EEPROM-based configuration.
Other companies in the same industry, closest in size